New England Revolution’s Alston to undergo treatment for leukemia

New England Revolution defender Kevin Alston is set to undergo treatment for chronic myelogenous leukemia (CML).

New England Revolution defender Kevin Alston is set to undergo treatment for chronic myelogenous leukemia (CML).

The 24-year old former USA youth international has been diagnosed with the rare but treatable condition and will now focus on overcoming the cancer of the white blood cells.

"The Revolution fully supports Kevin as he begins treatment," Revolution general manager Michael Burns said in a statement.

"Right now, the most important thing for Kevin, and his family, is to concentrate on returning to full health. Kevin's had a tremendous attitude since the diagnosis and his positivity is an inspiration for all of us.”

Alston joined the Revs in 2009 and has appeared in 116 MLS matches for the club. He was a MLS All-Star in 2010.

 
The game is about opinions. Make yours heard! Join the tribalfootball.com nation on Facebook today: Facebook.com/tribalfootball

Have your say